Our Interactive HIV/HCV Drug Therapy web application is now live!
This website application incorporates HIV and HCV pharmacology and drug interaction information in an easy-to-use, searchable and interactive format.
Drug Interaction Summary Tables
Concise, colour-coded quick reference charts for use in conjunction with our drug interaction application. These summary charts will be replacing the previous pdf tables which are no longer being updated. These tables are also available in a consolidated handbook in English and French. For more detailed drug interaction information, please visit our app.
|Acid suppressing Agents|
|Analgesics: opioids, opioid substitution, non-narcotics|
|Anti-infectives: azoles and macrolides|
|Anti-infectives: TB drugs|
|Hepatitis C drugs|
|Cardiovascular drugs: antihypertensives, digoxin|
|Cardiovascular drugs: antiplatelets, anticoagulants|
|Cardiovascular drugs: lipid-lowering agents|
|Genitourinary drugs: erectile dysfunction, pulmonary arterial hypertension|
|Genitourinary drugs: BPH, LUTS|
|Hormonal therapy: gender affirming|
|Hormonal therapy: contraceptives, hormone replacement therapy|
|Vitamins, herbals, body-building supplements|
|Miscellaneous: ergot alkaloids, colchicine|
- Antiretroviral Treatment Options for Patients on DAAs – Summary
- Drug Metabolism and Transporter Characteristics of Antiretrovirals and Hepatitis C Directly Acting Antivirals
For additional drug information, please visit the Additional Information for Healthcare Professionals page.
The information in this site is intended for use by and with experienced physicians and pharmacists. The information is not intended to replace sound professional judgment in individual situations, and should be used in conjunction with other reliable sources of information. Due to the rapidly changing nature of information about HIV treatment and therapies, users are advised to recheck the information contained herein with the original source before applying it to patient care. Decisions about particular medical treatments should always be made in consultation with a qualified medical practitioner knowledgeable about HIV-related illness and the treatments in question.